Literature DB >> 3177665

NE turnover in genetically hypertensive rats of Lyon strain. II. Peripheral organs.

M Sautel1, J Sacquet, M Vincent, J Sassard.   

Abstract

The peripheral sympathetic nervous system (SNS) is a major determinant of blood pressure and is likely to be involved in the pathophysiology of hypertension. Because SNS activity varies among organs, we measured the in vivo turnover (TO) of norepinephrine (NE) in seven organs of 5- and 22-wk-old genetically hypertensive (LH), normotensive (LN), and low blood pressure (LL) rats of the Lyon strains. The TO of NE was found normal in the superior cervical ganglia and decreased in the heart of 5-wk-old LH rats compared with both LL and LN controls. This suggests that sympathetic cardiac innervation may not be involved in the development of hypertension. On the contrary, an increased TO of NE in the kidney cortex and an elevated TO of dopamine associated with an increased epinephrine content in the adrenal medulla were observed in 5-wk-old LH rats, which could participate in the development of hypertension in the Lyon model.

Entities:  

Mesh:

Year:  1988        PMID: 3177665     DOI: 10.1152/ajpheart.1988.255.4.H736

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  Cutting edge: Sympathetic nervous system increases proinflammatory cytokines and exacerbates influenza A virus pathogenesis.

Authors:  Kristie M Grebe; Kazuyo Takeda; Heather D Hickman; Adam L Bailey; Adam M Bailey; Alan C Embry; Jack R Bennink; Jonathan W Yewdell
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

2.  Sympathetic nervous system control of anti-influenza CD8+ T cell responses.

Authors:  Kristie M Grebe; Heather D Hickman; Kari R Irvine; Kazuyo Takeda; Jack R Bennink; Jonathan W Yewdell
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-13       Impact factor: 11.205

3.  Interkingdom signaling induces Streptococcus pneumoniae biofilm dispersion and transition from asymptomatic colonization to disease.

Authors:  Laura R Marks; Bruce A Davidson; Paul R Knight; Anders P Hakansson
Journal:  MBio       Date:  2013-07-23       Impact factor: 7.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.